CardioComm Solutions Inc (EKG):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:CardioComm Solutions Inc (EKG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6592
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CardioComm Solutions Inc (CardioComm) is a medical technology company that offers software solutions for information management systems in cardiovascular medicine and telemedicine. The company offers software engineering of computer based electrocardiogram management and reporting software. Its products include software, hardware, software modules and other products. CardioComm provides ECG management services and enterprise solutions. The company also offers PC and LAN based products, internet based SAAS and ASP software, a medical ECG service, arrhythmia monitoring ECG protocols and supports traditional transtelephonic transmissions through wireless communication. The company caters to medical diagnostic and consumer market industries. It markets its products in Canada and the US. CardioComm is headquartered in North York, Ontario, Canada.

CardioComm Solutions Inc (EKG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CardioComm Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CardioComm Solutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
CardioComm Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CardioComm Solutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
CardioComm Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CardioComm Solutions Inc, Medical Equipment, Deal Details 10
Partnerships 10
Biotricity Enters into Licensing Agreement with CardioComm Solutions 10
CardioComm Solutions Enters into Partnership with Visiomed Group 11
CardioComm Solutions and Vigilance Form Joint Venture 12
CardioComm Solutions Enters Into Co-Development Agreement With Monebo Technologies For ECG Interpretation Software 13
CardioComm Solutions Enters Into Technology Integration Agreement With Royal Philips Electronics 15
CardioComm Solutions Enters Into Technology Integration Agreement With TZ Medical 16
CardioComm Solutions Enters Into Distribution Agreement With TZ Medical 17
Equity Offering 18
CardioComm Solutions Completes First Tranche Of Private Placement For US$0.1 Millon 18
CardioComm Solutions Completes Private Placement Of Units For US$0.12 Million 19
CardioComm Solutions Completes Private Placement Of Units For US$1.55 Million 20
CardioComm Solutions Completes Private Placement Of Common Stock For US$1 Million Upon Exercise Of Warrants 22
CardioComm Solutions Inc – Key Competitors 23
CardioComm Solutions Inc – Key Employees 24
CardioComm Solutions Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Apr 30, 2018: Cardiocomm solutions reports a profitable fy2017 and revenue growth 26
May 31, 2017: CardioComm Solutions Reports a Profitable Start to 2017 and Net Positive Cash Flow over the Last Four Fiscal Quarters 27
May 02, 2017: 2016 Year End Financials Confirm Cardiocomm Solutions Is at an Inflection Point as a Recognized Medical Solutions Provider 28
Corporate Communications 29
Nov 23, 2017: CardioComm Solutions Announces Addition of Banking Veteran to Its Board of Directors 29
Oct 25, 2017: Cardiocomm Solutions Annouces Updates To Its Board Of Directors 30
Product News 31
Dec 18, 2017: Cardiocomm Solutions Releases Gems Home Flex Software for Apple’s Mac and Windows’ Computer Operating Systems 31
Other Significant Developments 32
Feb 22, 2018: Cardiocomm Solutions Participates in Ontario Trade Mission to Japan and Korea 32
Apr 24, 2017: Carespan to Integrate Cardiocomm Solutions’ Electrocardiogram Toolset Into Its Virtual Clinic 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
CardioComm Solutions Inc, Medical Equipment, Key Facts, 2017 2
CardioComm Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
CardioComm Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CardioComm Solutions Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
CardioComm Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CardioComm Solutions Inc, Deals By Market, 2012 to YTD 2018 8
CardioComm Solutions Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Biotricity Enters into Licensing Agreement with CardioComm Solutions 10
CardioComm Solutions Enters into Partnership with Visiomed Group 11
CardioComm Solutions and Vigilance Form Joint Venture 12
CardioComm Solutions Enters Into Co-Development Agreement With Monebo Technologies For ECG Interpretation Software 13
CardioComm Solutions Enters Into Technology Integration Agreement With Royal Philips Electronics 15
CardioComm Solutions Enters Into Technology Integration Agreement With TZ Medical 16
CardioComm Solutions Enters Into Distribution Agreement With TZ Medical 17
CardioComm Solutions Completes First Tranche Of Private Placement For US$0.1 Millon 18
CardioComm Solutions Completes Private Placement Of Units For US$0.12 Million 19
CardioComm Solutions Completes Private Placement Of Units For US$1.55 Million 20
CardioComm Solutions Completes Private Placement Of Common Stock For US$1 Million Upon Exercise Of Warrants 22
CardioComm Solutions Inc, Key Competitors 23
CardioComm Solutions Inc, Key Employees 24
CardioComm Solutions Inc, Other Locations 25
CardioComm Solutions Inc, Subsidiaries 25

List of Figures
CardioComm Solutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
CardioComm Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
CardioComm Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
CardioComm Solutions Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
CardioComm Solutions Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CardioComm Solutions Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
CardioComm Solutions Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CardioComm Solutions Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[CardioComm Solutions Inc (EKG):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Buy It Direct Ltd:企業の戦略的SWOT分析
    Buy It Direct Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Clinical Laserthermia Systems AB (CLS B):企業の財務・戦略的SWOT分析
    Clinical Laserthermia Systems AB (CLS B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline …
  • Koninklijke Ahold Delhaize N.V.:企業の戦略・SWOT・財務情報
    Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report Summary Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Compass Minerals International Inc (CMP):企業の財務・戦略的SWOT分析
    Compass Minerals International Inc (CMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Oncodesign SA (ALONC):企業の財務・戦略的SWOT分析
    Summary Oncodesign SA (Oncodesign) is a bio pharmaceutical company that discovers drugs to treat diseases with unmet medical needs. It is investigating LRRK2 inhibitor to treat Parkinson’s disease, RIPK2 inhibitor against autoimmune diseases, MNK1/2 inhibitor targeting cancer. The company offers dru …
  • Vivartia Holdings SA.:企業の戦略的SWOT分析
    Vivartia Holdings SA. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Marmen Inc:企業の戦略的SWOT分析
    Marmen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Nevro Corp (NVRO):医療機器:M&Aディール及び事業提携情報
    Summary Nevro Corp (Nevro) is a medical device company that offers products for the treatment of chronic pain. The company develops and commercializes senza spinal cord stimulation system (SCS), an evidence-based neuromodulation platform. Its solution for chronic pain also includes HF10 Therapy, whi …
  • Cytox Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437):企業の財務・戦略的SWOT分析
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products include pharmaceutical drugs for treating nutrition disorders, cancer, cardiovascular diseases, anti-tumor medication, respiratory medication, …
  • Systex Corp (6214):企業の財務・戦略的SWOT分析
    Systex Corp (6214) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Planung Transport Verkehr AG:企業の戦略的SWOT分析
    Planung Transport Verkehr AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Rovsing AS:企業の戦略・SWOT・財務分析
    Rovsing AS - Strategy, SWOT and Corporate Finance Report Summary Rovsing AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Southern Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Southern Research Institute (Southern Research) is an independent, non-profit, and scientific research organization that conducts research in the areas of preclinical drug development, advanced engineering, drug discovery, environmental protection, and others. The organization offers life sc …
  • New Sports Group Limited:企業のM&A・事業提携・投資動向
    New Sports Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New Sports Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Biotec Pharmacon ASA (BIOTEC):企業の財務・戦略的SWOT分析
    Summary Biotec Pharmacon ASA (Biotec Pharmacon) is a biopharmaceutical company that develops, manufactures and markets immune modulating compounds and cold adapted enzymes. The company provides products which are used in the areas of human medicine such as immunotherapy of cancer, general infection …
  • Midland Power Cooperative:企業の戦略的SWOT分析
    Midland Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Neurones SA (NRO):企業の財務・戦略的SWOT分析
    Neurones SA (NRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SQZ Biotechnologies Co:製薬・医療:M&Aディール及び事業提携情報
    Summary SQZ Biotechnologies Co (SQZ) develops cell-based therapies that harness the body’s natural immune system against cancer. The company utilizes CellSqueeze, a technology platform for engineering various cell functions as antigen presenting cells (APCs) for immune modulation to impact oncology …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆